Skip to main content

Table 3 Phase II Indicator Selection Criteria

From: Ending preventable maternal mortality: phase II of a multi-step process to develop a monitoring framework, 2016–2030

Relevance

• Indicator directly supports EPMM strategies for reducing preventable maternal mortality

• There is evidence that what the indicator measures is significantly associated with improved maternal health and survival

Importance

• Indicator resonates, and is valuable to decision makers and stakeholders

• Indicator “makes a difference” for improving maternal health and survival across countries and contexts

Interpretability & Usefulness

• There is good/strong evidence to support the process, or the outcome

• Results point to areas for improvement and can advance strategic planning, policy or programming at different levels of the system

Validity

• Indicator measures what it is supposed to measure

• Indicator has been field-tested and used

• Indicator makes sense logically and scientifically

Feasibility & Data Availability

• Based on the best available data of acceptable quality

• Data can be obtained with reasonable and affordable efforts in timely manner

• Data does not overly increase reporting burden on countries

Harmonization

• Indicator strengthens or compliments existing efforts

• Indicator is recommended and being used by leading experts and organizations

• Indicator lacks redundancy and does not measure something already captured under other indicators